Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

By M. Bristow, L. Saxon, J. Boehmer, S. Krueger, D. Kass, T. De Marco, P. Carson, L. DiCarlo, D. DeMets, B. G. White and 2 more. New England Journal of Medicine, 2004

5,317 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/bb0f33d05addb6bc93e6e53f0cc37b28be47009a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. J. Cleland
3. M. Flemmer
4. P. Marik
5. Gerasimos Filippatos
6. J. Januzzi
7. T. Horwich
8. L. Tavazzi

Citations in the corpus

• Reduction in inappropriate therapy and mortality through ICD programming. (2012, neutral): “Inappropriate therapy 105 (20) 21 (4) 26 (5) <0.”
• 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013, methodology): “54 The CARE-HF and COmparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trials evaluated the effects of CRT-P on HF hospitalizations and all-cause mortality.(55,56) A recent meta-analysis showed that, in these patients, CRT improved symptoms and reduced all-cause mor”
• Narrative Review (2012, background): “Cardiac resynchronization therapy with an implantable pacemaker defibrillator appears to offer greater benefit than CRT with a pacemaker alone.(120) At this time, CRT should not be used as salvage therapy in patients with ADHF but should be considered in suitable candidates once the patient’s condit”
• ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006, background): “In patients with a poor functional status (NYHA functional class III or IV), reduced ventricular function (LVEF less than or equal to 35%), and a wide-QRS complex (at least 120 ms), biventricular pacing without ICD therapy has consistently led to a reduction of mortality and hospital admissions for ”
• Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) (2005, background): “Study enrollment criteria consisted of (1) chronic atrial fibrillation for >30 days; (2) requirement for AV node ablation and pacing therapy to manage medically refractory rapid ventricular rates; (3) symptoms limiting ambulation to <450 m with a 6-minute hallway walk test; and (4) stable medical th”
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. (2005, methodology): “The COMPANION trial included patients with left ventricular systolic dysfunction, wide QRS complex suggesting dyssynchrony and heart failure and showed that implantation of an ICD in combination with resynchronization in patients with severe heart failure reduced mortality and morbidity (See under R”